Vimarsana
Biggest News Aggregation in the World

Page 3 - Accustem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accustem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accustem Today - Breaking & Trending Today

AccuStem Sciences, Inc. Announces DTC Eligibility - Vimarsana News

AccuStem Sciences, Inc. Announces DTC Eligibility

LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC Pink: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce

AccuStem Sciences, Inc. Appoints New Executive Leadership Team - Company plans to uplist to the Nasdaq Capital Market - Vimarsana News

AccuStem Sciences, Inc. Appoints New Executive Leadership Team - Company plans to uplist to the Nasdaq Capital Market

Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes

AccuStem Sciences, Inc. Appoints New Executive Leadership Team - Vimarsana News

AccuStem Sciences, Inc. Appoints New Executive Leadership Team

Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 -- AccuStem Sciences, Inc. , a life sciences company dedicated to improving outcomes for patients with cancer,... | March 4, 2022

AccuStem Sciences, Inc. Appoints New Executive Leadership Team - Vimarsana News

AccuStem Sciences, Inc. Appoints New Executive Leadership Team

Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes

Tiziana Life Sciences : StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort - Vimarsana News

Tiziana Life Sciences : StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort

New York, March 1, 2022 - Tiziana Life Sciences Ltd. reports that its' former subsidiary, AccuStem Sciences, Inc. , today announced publication of new data in the European Journal of Cancer.... | March 1, 2022